Showing 1 - 10 results of 10 for search 'Victor H. F. Lee', query time: 0.05s Refine Results
  1. 1
    Prediction of sensitivity to gefitinib/erlotinib for EGFR mutations in NSCLC based on structural interaction fingerprints and multilinear principal component analysis

    Prediction of sensitivity to gefitinib/erlotinib for EGFR mutations in NSCLC based on structural interaction fingerprints and multilinear principal component analysis by Bin Zou, Victor H. F. Lee, Hong Yan

    Published 2018-03-01
    Get full text
    Article
  2. 2
    Contribution of EGFR and ErbB-3 Heterodimerization to the EGFR Mutation-Induced Gefitinib- and Erlotinib-Resistance in Non-Small-Cell Lung Carcinoma Treatments.

    Contribution of EGFR and ErbB-3 Heterodimerization to the EGFR Mutation-Induced Gefitinib- and Erlotinib-Resistance in Non-Small-Cell Lung Carcinoma Treatments. by Debby D Wang, Lichun Ma, Maria P Wong, Victor H F Lee, Hong Yan

    Published 2015-01-01
    Get full text
    Article
  3. 3
    Deciphering mechanisms of acquired T790M mutation after EGFR inhibitors for NSCLC by computational simulations

    Deciphering mechanisms of acquired T790M mutation after EGFR inhibitors for NSCLC by computational simulations by Bin Zou, Victor H. F. Lee, Lijiang Chen, Lichun Ma, Debby D. Wang, Hong Yan

    Published 2017-07-01
    Get full text
    Article
  4. 4
    A Novel DPYD Variant Associated With Severe Toxicity of Fluoropyrimidines: Role of Pre-emptive DPYD Genotype Screening

    A Novel DPYD Variant Associated With Severe Toxicity of Fluoropyrimidines: Role of Pre-emptive DPYD Genotype Screening by Chi C. Tong, Ching W. Lam, Ka O. Lam, Victor H. F. Lee, Mai-Yee Luk

    Published 2018-07-01
    Get full text
    Article
  5. 5
    The Role of Natural Killer Cells in the Tumor Immune Microenvironment of EBV-Associated Nasopharyngeal Carcinoma

    The Role of Natural Killer Cells in the Tumor Immune Microenvironment of EBV-Associated Nasopharyngeal Carcinoma by Shuzhan Li, Wei Dai, Ngar-Woon Kam, Jiali Zhang, Victor H. F. Lee, Xiubao Ren, Dora Lai-Wan Kwong

    Published 2024-03-01
    Get full text
    Article
  6. 6
    Long-term outcomes and recurrence pattern of 18F-FDG PET-CT complete metabolic response in the first-line treatment of metastatic colorectal cancer: a lesion-based and patient-based analysis

    Long-term outcomes and recurrence pattern of 18F-FDG PET-CT complete metabolic response in the first-line treatment of metastatic colorectal cancer: a lesion-based and patient-base... by Keith W. H. Chiu, Ka-On Lam, H. An, Gavin T. C. Cheung, Johnny K. S. Lau, Tim-Shing Choy, Victor H. F. Lee

    Published 2018-07-01
    Get full text
    Article
  7. 7
    Correlations of tumour permeability parameters with apparent diffusion coefficient in nasopharyngeal carcinoma

    Correlations of tumour permeability parameters with apparent diffusion coefficient in nasopharyngeal carcinoma by Alan W.L. Mui, Anne W.M. Lee, W.T. Ng, Victor H.F. Lee, Varut Vardhanabhuti, Shei S.Y. Man, Daniel T.T. Chua, X.Y. Guan

    Published 2022-10-01
    Get full text
    Article
  8. 8
    Optimal time for early therapeutic response prediction in nasopharyngeal carcinoma with functional magnetic resonance imaging

    Optimal time for early therapeutic response prediction in nasopharyngeal carcinoma with functional magnetic resonance imaging by Alan W.L. Mui, Anne W.M. Lee, Wai-Tong Ng, Victor H.F. Lee, Varut Vardhanabhuti, Shei-Yee Man, Daniel T.T. Chua, Xin-Yuan Guan

    Published 2023-07-01
    Get full text
    Article
  9. 9
    Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma.

    Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma. by Victor H F Lee, Anthony W I Lo, Chun-Yin Leung, Wai-Hung Shek, Dora L W Kwong, Ka-On Lam, Chi-Chung Tong, Chun-Kin Sze, To-Wai Leung

    Published 2016-01-01
    Get full text
    Article
  10. 10
    Safety of two-dose COVID-19 vaccination (BNT162b2 and CoronaVac) in adults with cancer: a territory-wide cohort study

    Safety of two-dose COVID-19 vaccination (BNT162b2 and CoronaVac) in adults with cancer: a territory-wide cohort study by Wei Kang, Jessica J. P. Shami, Vincent K. C. Yan, Xuxiao Ye, Joseph E. Blais, Xue Li, Victor H. F. Lee, Celine S. L. Chui, Francisco T. T. Lai, Eric Y. F. Wan, Carlos K. H. Wong, Ian C. K. Wong, Esther W. Chan

    Published 2022-05-01
    Get full text
    Article

Search Tools: